Clinical Trial Update: Effects of Tiotropium/Olodaterol on Cardio-pulmonary Exercise Capacity in Patients With Hyperinflated Chronic Obstructive Pulmonary Disease [ACHIEVE] [NA]

View source ↗

Summary

A completed clinical trial studying the effects of the tiotropium/olodaterol combination on cardio-pulmonary exercise capacity in hyperinflated COPD patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Stiolto Respimat (tiotropium + olodaterol)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: COMPLETED